The effects of baseline length in Computed Tomography perfusion of liver
暂无分享,去创建一个
Alessandro Bevilacqua | Domenico Barone | Silvia Malavasi | Giampaolo Gavelli | A. Bevilacqua | D. Barone | G. Gavelli | Silvia Malavasi
[1] Apostolos Karantanas,et al. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps , 2018, Acta radiologica.
[2] Jin Mo Goo,et al. Quantitative Computed Tomography Imaging Biomarkers in the Diagnosis and Management of Lung Cancer , 2015, Investigative radiology.
[3] Anastasia Bezerianos,et al. Comparing Similarity Perception in Time Series Visualizations , 2019, IEEE Transactions on Visualization and Computer Graphics.
[4] Massimo Mischi,et al. Mathematical Models of Contrast Transport Kinetics for Cancer Diagnostic Imaging: A Review , 2016, IEEE Reviews in Biomedical Engineering.
[5] Graham M. Treece. The Bitonic Filter: Linear Filtering in an Edge-Preserving Morphological Framework , 2016, IEEE Transactions on Image Processing.
[6] Yuko Nakamura,et al. Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival. , 2018, European journal of radiology.
[7] Arthur Tenenhaus,et al. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma? , 2018, European Radiology.
[8] Agostino Gibaldi,et al. Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors. , 2015, Academic radiology.
[9] Konstantin Nikolaou,et al. Clinical applications for dual energy CT versus dynamic contrast enhanced CT in oncology. , 2015, European journal of radiology.
[10] M. Maurin,et al. REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .
[11] Alessandro Bevilacqua,et al. A novel approach for semi-quantitative assessment of reliability of blood flow values in DCE-CT perfusion , 2017, Biomed. Signal Process. Control..
[12] G. Brix,et al. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[13] C. V. van Kuijk,et al. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities. , 2010, Ultrasound in medicine & biology.
[14] Hiroshi Honda,et al. Clinical application of radiation dose reduction for head and neck CT. , 2018, European Journal of Radiology.
[15] Alessandro Bevilacqua,et al. Automatic detection of misleading blood flow values in CT perfusion studies of lung cancer , 2016, Biomed. Signal Process. Control..
[16] D. Hill,et al. Non-rigid image registration: theory and practice. , 2004, The British journal of radiology.
[17] Ting-Yim Lee. Functional CT: physiological models , 2002 .
[18] Ramsey D Badawi,et al. CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates , 2018, European Radiology.
[19] Tao Jiang,et al. Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST) , 2012, Investigative radiology.
[20] Y. Ohno,et al. CT hepatic perfusion measurement: comparison of three analytic methods. , 2012, European journal of radiology.
[21] A K Dixon,et al. Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.
[22] Konstantin Nikolaou,et al. Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. , 2019 .
[23] Lorenzo Faggioni,et al. Is liver perfusion CT reproducible? A study on intra- and interobserver agreement of normal hepatic haemodynamic parameters obtained with two different software packages. , 2017, The British journal of radiology.
[24] Torkel B. Brismar,et al. Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension , 2016, European Radiology.
[25] Alessandro Bevilacqua,et al. Liver CT perfusion: which is the relevant delay that reduces radiation dose and maintains diagnostic accuracy? , 2019, European Radiology.
[26] N. Holalkere,et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. , 2007, Radiology.
[27] David H. Kim,et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. , 2010, AJR. American journal of roentgenology.
[28] Cynthia H McCollough,et al. Evaluation of strategies to reduce radiation dose in perfusion CT imaging using a reproducible biologic phantom. , 2013, AJR. American journal of roentgenology.
[29] Peter N. Burns,et al. The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib , 2018, European Radiology.
[30] Kostas Marias,et al. Investigating the Correlation of Ktrans With Semi-Quantitative MRI Parameters Towards More Robust and Reproducible Perfusion Imaging Biomarkers in Three Cancer Types , 2019, IEEE Journal of Biomedical and Health Informatics.
[31] Martin J Graves,et al. A semi-automatic method for the extraction of the portal venous input function in quantitative dynamic contrast-enhanced CT of the liver. , 2017, The British journal of radiology.
[32] Mark Parson,et al. Perfusion Abnormalities are Frequently Detected by Early CT Perfusion and Predict Unfavourable Outcome Following Severe Traumatic Brain Injury , 2017, World Journal of Surgery.
[33] Chaan S Ng,et al. Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. , 2013, Radiology.
[34] Nathalie Lassau,et al. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. , 2013, European journal of radiology.
[35] Tetsuya Kaneko,et al. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. , 2002, Journal of hepatology.
[36] Alessandro Bevilacqua,et al. Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. , 2014, Academic radiology.
[37] Ernst Klotz,et al. Technical prerequisites and imaging protocols for CT perfusion imaging in oncology. , 2015, European journal of radiology.
[38] Ernst Klotz,et al. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma. , 2016, Radiology.
[39] Naveen M. Kulkarni,et al. Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. , 2016, AJR. American journal of roentgenology.
[40] S Skornitzke,et al. Qualitative and quantitative evaluation of rigid and deformable motion correction algorithms using dual-energy CT images in view of application to CT perfusion measurements in abdominal organs affected by breathing motion. , 2015, The British journal of radiology.
[41] L. Loizou,et al. Multi-detector CT: Liver protocol and recent developments. , 2017, European journal of radiology.
[42] D Balvay,et al. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. , 2013, Diagnostic and interventional imaging.
[43] Roberta Fusco,et al. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases , 2017, PloS one.
[44] Hatem Alkadhi,et al. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience , 2016, CardioVascular and Interventional Radiology.
[45] Rachida Lebtahi,et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. , 2017, The Lancet. Oncology.
[46] B. V. Van Beers,et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. , 2000, Clinical science.
[47] M. Ronot,et al. CT and MR perfusion techniques to assess diffuse liver disease , 2019, Abdominal Radiology.
[48] K. Bae,et al. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. , 2010, Radiology.